NCT07713017 Combined Effects of Aerobic Exercise and Strength Training Among Post CABG Patients
| NCT ID | NCT07713017 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Coronary Atherosclerosis of Bypass Graft |
| Study Type | INTERVENTIONAL |
| Enrollment | 42 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 42 participants in total. It began in 2026-06-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Title of study Combined effects aerobic exercise and strength training on functional capacity, cardiorespiratory fitness and quality of life with cardiac rehabilitation phase II among post CABG patients Objective (s) of the study To investigate the combined effects of aerobic exercise and strength training on functional capacity, cardiorespiratory fitness and quality of life with cardiac rehabilitation phase II among post CABG patients. Methodology (Design, sample size, sampling technique, Study setting, inclusion and exclusion criteria and Tool) Design: Randomized Controlled Trial Sample Size: 42 patients Sampling Technique: Convenient sampling technique will be used for selection of patient after that simple random sampling technique will be used for randomization among groups Study Setting: Hospital Setting SF-12, 6-min walk test, VO2 max, step test This study will not harm any fundamental rights of the patients and will consider and respect the preferences of patients.
Eligibility Criteria
Inclusion Criteria: * Both genders (male, female) * Patient who underwent a successful CABG (no complications during surgery and/or in the following weeks) * Patients willing to participate in the phase II cardiac rehabilitation program. * Age between 30 to 60 years * Patients having no impairment in the musculoskeletal system Exclusion Criteria: * Patients with unstable congestive heart failure and symptoms of significant myocardial ischemia, including chest pain * Patients with uncontrolled diabetes mellitus or hypertension. * Patients with any motor or neurological impairment * Patients with severe disturbance of consciousness, having an orthopedic problem and critical limb ischemia
Contact & Investigator
Arjumand Bano, MS
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07713017 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 60 Years, studying Coronary Atherosclerosis of Bypass Graft. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07713017 currently recruiting?
Yes, NCT07713017 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT07713017 trial being conducted?
This trial is being conducted at Sialkot, Pakistan.
Who is sponsoring the NCT07713017 clinical trial?
NCT07713017 is sponsored by Riphah International University. The principal investigator is Arjumand Bano, MS at Riphah International University. The trial plans to enroll 42 participants.